MapLight Therapeutics, Inc. (MPLT)
↓ Download CSVKey ratios (FY2025)
-35.2%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating Income | -$169.08M | -$82.95M | — |
| Net Income | -$161.15M | -$77.58M | — |
| EPS (Diluted) | $-18.56 | $-105.38 | — |
| Total Assets | $479.51M | $136.92M | — |
| Total Liabilities | $21.14M | $21.72M | — |
| Shareholders' Equity | $458.37M | -$193.63M | -$117.58M |
| Cash & Equivalents | $46.73M | $38.25M | — |
| Operating Cash Flow | -$138.14M | -$78.81M | — |
| Capital Expenditures | $473.0K | $770.0K | — |
| Shares Outstanding | 44.02M | 761.3K | — |